24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Sisram Medical
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
22:26
Monday is doing almost everything right. Wall Street still isn’t convinced
19:44
Defense stocks soar as Israel’s new IPOs split into winners and losers
17:32
Full list of Israeli high-tech layoffs in 2026
17:30
SciPlay cuts 20 jobs at its 300-person Israeli gaming hub
More stories
Buzz
Most popular
Daily
Weekly
1
Israeli AI startup Decart nearing $6 billion sale, Musk’s SpaceX circling
2
Israel set to reject $4.2 billion Zim sale despite buyers’ concessions
3
Talkspace co-founder Oren Frank dies at 60 after battle with cancer
4
Israel’s Iron Beam laser was hailed as a breakthrough. It still isn’t operational
5
Corma raises $60 million Seed to build AI designed to fight AI-powered cyberattacks
More news
Sisram Medical
5 stories about Sisram Medical
Fosun Whetted Our Appetite, Says Alma Lasers CEO
04.07.19
|
Golan Hazani
Fosun Pharma CEO Yifang Wu and Alma Lasers CEO Lior Dayan gave Calcalist their first joint interview since the Chinese conglomerate acquired the Israeli medical laser company in 2013
Fosun Pharma Inaugurates New Building for Israeli Subsidiary Sisram Medical
26.02.19
|
Golan Hazani
Fosun paid $240 million for a 95% stake in the Israeli cosmetic surgery in 2014, floating it on the Hong Kong Exchange in 2017
Fosun Pharma Subsidiary Sisram Medical Leases 11,000-Square-Meter Building in Caesarea
10.12.18
|
Dotan Levy
The ten-year lease is estimated at $1.7 million (NIS 6.3 million) per year. China’s Fosun Pharma bought Sisram in 2014 for $240 million, renaming it from Alma Lasers
Sisram Stock Price Down on Market Debut
19.09.17
|
Amarelle Wenkert
The Fosun Pharma subsidiary debuted on the Hong Kong Stock Exchange Tuesday
Sisram Medical Seeks to Raise Up To $176 Million in Hong Kong IPO
10.09.17
|
Amarelle Wenkert
On September 5, the Fosun Pharma subsidiary submitted a prospectus to the Hong Kong Stock Exchange